ITRM
Iterum Therapeutics plc
Set alert
0.03 USD 0.00 0.00%
0.0283 Day range 0.047
0.808 52-week range 3.02
- YTD
- -91.04%
- 1 year
- -96.91%
- Open
- 0.0415
- Prev close
- 0.03
- Mkt cap
- 48.98M
- Vol
- 49.30M
- Avg vol
- 2.88M
- EPS
- -1.76
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0283
- High
- 0.047
- Forward P/E
- -2.70
- Beta
- 2.25
- Short ratio
- 0.46
- Inst. own
- 8.99%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 14, 2024
- 50-d avg
- 1.63
- 200-d avg
- 1.40
- 1y target
- 7.50
Financial health
Altman Z-Score
-23.98 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -1.4×
FY 2016 5y median -0.7× FY 2024
P/S 0.0×
FY 2016 5y median 0.0× FY 2024
P/B -8.5×
FY 2016 5y median -4.0× FY 2024
P/FCF -1.3×
FY 2016 5y median -1.3× FY 2024
EV/EBITDA -2.6×
FY 2016 5y median -1.1× FY 2024
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2024
FCF Yield -76.8%
FY 2016 5y median -76.8% FY 2024
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2024
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2024
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2024
ROE 607.1%
FY 2016 5y median 102.9% FY 2024
ROIC -45.1%
FY 2016 5y median -45.1% FY 2024
ROA -55.6%
FY 2016 5y median -100.1% FY 2024
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2024
Operating Income 60.6%
FY 2016 FY 2024
EPS (diluted) 57.4%
FY 2016 FY 2024
Free Cash Flow 32.0%
FY 2016 FY 2024
Financial Health
Current Ratio 1.4×
FY 2016 5y median 1.9× FY 2024
Quick Ratio 1.4×
FY 2016 5y median 1.9× FY 2024
Debt / Equity -11.2×
FY 2016 5y median -1.0× FY 2024
Net Debt / EBITDA -1.0×
FY 2016 5y median -0.4× FY 2024
Interest Coverage -7.4×
FY 2016 5y median -4.4× FY 2024
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2024
Annual · latest fiscal year ends 2024-12-31